← All candidates
14 insider buys in the last year — $2.80M in all.
28 filings on record.
ANVSAnnovis Bio, Inc.
NYSE · Healthcare · $47.72M
$1.12
14 insider buys in the last year — $2.80M in all.
Nothing in the last fortnight.
No price data yet — the yfinance scanner hasn't produced bars for ANVS.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$47.72M
Float
35.3M
83% public
Short % float
Pro
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Director
Hoffman Michael B
Bought $2.00M on Oct 28 — 975,610 sh @ $2.05, held direct, 40% of their stake.
0 of 1 position beat the S&P
President & CEO
Maccecchini Maria-Luisa
Bought $200.0K on Oct 28 — 97,561 sh @ $2.05, held direct, 8.0% of their stake.
0 of 1 position beat the S&P
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
2 filingsnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
23 more transactions on Pro →Context
Wall St
$12.50 avg target
+1016.1% vs today · 2 analysts · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
The file stays open
28 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice